Calidi Biotherapeutics, Inc. (CLDI)
USD 1.44
(-16.76%)
USD 1.44
(-16.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -29.21 Million USD | -14.9% |
| 2022 | -25.42 Million USD | -850.78% |
| 2021 | 3.38 Million USD | 142.67% |
| 2020 | -7.93 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -5.76 Million USD | 20.18% |
| 2024 Q1 | -7.22 Million USD | -103.52% |
| 2023 Q4 | -3.55 Million USD | -75.4% |
| 2023 FY | -29.21 Million USD | -14.9% |
| 2023 Q3 | -2.02 Million USD | 52.58% |
| 2023 Q2 | -4.26 Million USD | -91.88% |
| 2023 Q1 | -2.22 Million USD | 14.0% |
| 2022 Q1 | 1.46 Million USD | -65.94% |
| 2022 Q4 | -2.58 Million USD | -624.09% |
| 2022 Q3 | 493.57 Thousand USD | -88.14% |
| 2022 FY | -25.42 Million USD | -850.78% |
| 2022 Q2 | 4.16 Million USD | 184.59% |
| 2021 Q3 | -823.28 Thousand USD | 0.0% |
| 2021 FY | 3.38 Million USD | 142.67% |
| 2021 Q4 | 4.29 Million USD | 621.49% |
| 2020 FY | -7.93 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -28.96 Million USD | -0.877% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -238.462% |
| Armata Pharmaceuticals, Inc. | -69.04 Million USD | 57.686% |
| Actinium Pharmaceuticals, Inc. | -48.81 Million USD | 40.153% |
| Azitra, Inc. | -11.28 Million USD | -158.92% |
| Can-Fite BioPharma Ltd. | -7.63 Million USD | -282.709% |
| Chromocell Therapeutics Corporation | -7.38 Million USD | -295.838% |
| CEL-SCI Corporation | -32.36 Million USD | 9.732% |
| iBio, Inc. | -24.9 Million USD | -17.3% |
| Lineage Cell Therapeutics, Inc. | -21.48 Million USD | -35.977% |
| MAIA Biotechnology, Inc. | -19.77 Million USD | -47.758% |
| Matinas BioPharma Holdings, Inc. | -22.94 Million USD | -27.347% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -92.5% |
| NovaBay Pharmaceuticals, Inc. | -9.64 Million USD | -203.071% |
| NanoViricides, Inc. | -8.29 Million USD | -252.248% |
| Oragenics, Inc. | -20.65 Million USD | -41.443% |
| BiomX Inc. | -26.16 Million USD | -11.644% |
| BiomX Inc. | -26.16 Million USD | -11.644% |
| Protalix BioTherapeutics, Inc. | 8.31 Million USD | 451.492% |
| Palatin Technologies, Inc. | -29.73 Million USD | 1.749% |
| Scorpius Holdings, Inc. | -45.21 Million USD | 35.387% |